Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.
 

RSS icon
Top cardiology stories in Cardiology Business magazine in February 2022. The top stories this month included new information on COVID vaccine caused myocarditis and the FDA clearance of the first transcatheter dual-chamber leadless pacemaker system from Abbott.

The top 20 Cardiology Business stories for February 2022

The most popular stories on Cardiology Business in February 2022 focused on COVID-19 updates, new technologies, an Olympics controversy and much more. 

Hypertension patients benefit from new intervention focused on education, motivation and text messages

Improving the way we communicate with ED patients about their blood pressure could make a significant long-term impact on their health. 

How modified bioprosthetic heart valves could limit calcification, reduce need for TAVR

Bioprosthetic heart valves often express foreign sugars that trigger a response from the body's immune system. This immune response appears to be associated with calcification. 

FDA approves empagliflozin for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

The SGLT2 inhibitor, already approved for some high-risk heart failure patients, has now received a much wider approval. 

Myocarditis as seen on cardiac MRI in patients who recently received COVID-19 messenger RNA vaccination from a November 2021 imaging study. Image courtesy of the American Journal of Roentgenology (AJR)

New CDC guidance: Waiting longer between COVID-19 vaccine doses could reduce risk of heart damage

Waiting a few additional weeks, the agency wrote, could help limit myocarditis or pericarditis among young adults.

Thumbnail

Cardiologists identify 162 genes responsible for coronary heart disease

The team's findings, one researcher said, "could eventually make a huge impact on many patients lives."

A team of researchers at Gladstone, including Bárbara González Terán shown here seated, developed a novel algorithm method for identifying genetic variants that are likely to play important roles in congenital heart disease. This opens up opportunities to accelerate research into this serious condition. Photo by Michael Short/Gladstone Institutes

Algorithm helps sort genetic data to improve our understanding of congenital heart disease

Researchers at Gladstone Institutes developed a new algorithm method for identifying genetic variant combinations that are likely to play important roles in congenital heart disease.

Thumbnail

USPSTF shares updated recommendations on statin use to prevent CVD

The public comment period for these recommendations ends on March 21.

Displaying 345 - 352 of 965
Design by Adaptive Theme